AIFA - Allergy and Immunology Foundation of Australasia
To be eligible for an AIFA grant the Chief Investigator must be an ASCIA member and the research needs to be carried out by the chief investigator and designated team in a non-profit institution in Australia or New Zealand.
Thank you to our generous donors and sponsors for their support, which has allowed us to offer a total of $110,000 to be granted to immunology and allergy research in 2020:
☐$40,000 - AIFA Food Allergy Research Grant
☐$30,000 - AIFA Allergy (other than food allergy) or Autoimmunity Research Grant
☐$15,000 - AIFA Primary Immunodeficiencies Clinical Research Grant (supported by CSL Behring)
☐$15,000 - AIFA Hereditary Angioedema Clinical Research Grant (supported by CSL Behring)
☐$10,000 - AIFA Food Allergy Research Grant (supported by DBV Technologies)
Last year a total of $120,000 in AIFA grants was awarded to research projects and to read about these go to www.allergyimmunology.org.au/projects
Thank you also to our independent and voluntary expert grant selection panel who select AIFA research grants each year through a robust selection process.
AIFA is now seeking donations and support for the 2021 grants.
By donating to AIFA, you can be reassured that 100% of donations to AIFA directly fund allergy/immunology research grants.
- All donations of $100 or more are perpetually acknowledged on the AIFA website www.allergyimmunology.org.au/our-supporters/donors
- Significant donors (of $10,000 or more) may request targeted research project funding in particular areas.
AIFA research grants encourage:
- Emerging researchers who may not yet receive grants from the NHMRC or other organisations
- Innovative research that requires seed funding
- Collaborative research projects conducted throughout Australia and New Zealand
- Projects that will translate to better treatment and care for patients with allergy and other immune diseases
AIFA was established in 2013 by ASCIA, the peak professional body for allergy and clinical immunology in Australasia. The aim of AIFA is to improve the health and care of people with allergy and other immune diseases by funding medical research and raising awareness of these disorders in Australia and New Zealand.
Allergy and other immune system disorders (primary immunodeficiencies and autoimmune diseases) are amongst the most important chronic diseases and public health issues in Australia and New Zealand, affecting around 25% of the population. Funding of research into allergy and other immune diseases is vital for the prevention and treatment of these diseases, and to ultimately find cures.
Content updated August 2020